| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 08/07/2002 | CN1362640A Silver-halides photo-sensitive emulsion layer with reinforced photographic photosensibility |
| 08/07/2002 | CN1362397A Dialkoyl-halogen phenyl substituted keto-enol |
| 08/06/2002 | US6429317 Indane derivatives for antipsychotic compositions |
| 08/06/2002 | US6429316 Process for preparing pyrrolidone derivative |
| 08/06/2002 | US6429288 Peptides containing an arginine mimetic for the treatment of bone metabolic disorders, their production, and drugs containing these compounds |
| 08/06/2002 | US6428780 Modified amino acid |
| 08/01/2002 | WO2002059240A2 Hydroxy aromatic mannich base condensation products and the use thereof as soot dispersants in lubricating oil compositions |
| 08/01/2002 | WO2002059114A1 Lfa-1 antagonist compounds |
| 08/01/2002 | WO2002059087A1 Preparation of non-crystalline atorvastatin calcium |
| 08/01/2002 | WO2002059086A1 Carboxamides as fungicides in agriculture |
| 08/01/2002 | WO2002058657A1 Primary intermediates for oxidative coloration of hair |
| 08/01/2002 | WO2002058635A2 Nicotine immunogens and antibodies and uses thereof |
| 08/01/2002 | WO2002040461A3 Aminoalkoxybiphenyl carboxamides as histamine-3 receptor ligands and their therapeutic applications |
| 08/01/2002 | WO2002022572A3 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission) |
| 08/01/2002 | WO2002012190A3 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 08/01/2002 | WO2001090066A3 Method for obtaining pure n-vinyl pyrrolidone |
| 08/01/2002 | US20020103384 Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV |
| 08/01/2002 | US20020103239 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity |
| 08/01/2002 | US20020103168 Fungicide phenylimine derivatives |
| 08/01/2002 | US20020103164 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
| 08/01/2002 | US20020102380 Ionic compounds in which the anionic load has been delocalized; ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions including polymerization |
| 08/01/2002 | CA2433819A1 Carboxamides as fungicides in agriculture |
| 08/01/2002 | CA2429353A1 Lfa-1 antagonist compounds |
| 07/31/2002 | EP1226822A2 Promoter for production of nitric oxide or nitric oxide synthase, and cosmetic or pharmaceutical composition comprising the same |
| 07/31/2002 | EP1226139A2 Cyclized amide derivatives for treating or preventing neuronal damage |
| 07/31/2002 | EP1226108A1 Diaryl-enynes |
| 07/31/2002 | EP1226107A1 N-benzyl-p-phenylenediamine-derivatives containing colouring agents for keratin fibres and novel n-benzyl-p-phenylenediamine-derivatives |
| 07/31/2002 | EP1225886A2 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
| 07/31/2002 | EP1189884A4 Removal of contaminants from n-methyl-2-pyrrolidone |
| 07/31/2002 | EP0958290B1 1,4-dihydropyridin derivatives and their use in therapy |
| 07/31/2002 | EP0719267B1 Second messenger cell signaling inhibitors |
| 07/30/2002 | US6426365 CETP activity inhibitors |
| 07/30/2002 | US6426364 Nervous system or psychological disorders |
| 07/30/2002 | CA2148683C Potentiator of bacillus pesticidal activity |
| 07/30/2002 | CA2067614C Agent for improving dementia |
| 07/30/2002 | CA2056619C Method of inactivation of viral and bacterial blood contaminants |
| 07/25/2002 | WO2002057422A2 Ternary biomolecule/polymer/surface-based immobilization systems |
| 07/25/2002 | WO2002057274A1 A process for the synthesis of atorvastatin form v and phenylboronates as intermediate compounds |
| 07/25/2002 | WO2002057236A1 Phenyl derivatives |
| 07/25/2002 | WO2002057233A1 Mch antagonists and their use in the treatment of obesity |
| 07/25/2002 | WO2002057230A1 Il-8 receptor antagonists |
| 07/25/2002 | WO2002057229A1 FORM V CRYSTALLINE [R-(R*,R*)]-2-(4-FLUOROPHENYL)-ß,$G(D)-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1- HEPTANOIC ACID HEMI CALCIUM SALT. (ATORVASTATIN) |
| 07/25/2002 | WO2002057228A1 Atorvastatin calcium |
| 07/25/2002 | WO2002057215A2 Sodium channel modulators |
| 07/25/2002 | WO2002057211A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use |
| 07/25/2002 | WO2002042268A3 Ep4 receptor selective agonists in the treatment of osteoporosis |
| 07/25/2002 | WO2002032874A3 Substituted heterocyclic compounds for treating multidrug resistance |
| 07/25/2002 | WO2002002519A3 THROMBIN OR FACTOR Xa INHIBITORS |
| 07/25/2002 | US20020099224 Hydrolysis of [R (R*, R*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid esters with calcium hydroxide |
| 07/25/2002 | US20020099215 For therapy and prophylaxis of P-glycoprotein-mediated multidrug resistance |
| 07/25/2002 | US20020099089 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-N-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases |
| 07/25/2002 | US20020098999 Compounds for sustained release of orally delivered drugs |
| 07/25/2002 | DE10102322A1 New disubstituted and trisubstituted benzene derivatives useful as coagulation inhibitors for the treatment of thromboembolic diseases |
| 07/25/2002 | CA2447606A1 Ternary biomolecule/polymer/surface-based immobilization systems |
| 07/25/2002 | CA2436122A1 A process for the synthesis of atorvastatin form v and phenylboronates as intermediate compounds |
| 07/25/2002 | CA2434636A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use |
| 07/24/2002 | EP1224168A1 Antifungal enediynes |
| 07/24/2002 | EP1102743B1 Amide derivatives which are useful as cytokine inhibitors |
| 07/24/2002 | EP0977726B1 Process for esterification of amino acids and peptides |
| 07/24/2002 | EP0886647B1 Serine protease inhibitors |
| 07/24/2002 | EP0684945B1 Pyrazole- or isoxazole-substituted alkyl amide acat inhibitors |
| 07/24/2002 | CN1360577A Hydroxamic acid derivs. as matrix metalloprotease inhibitors |
| 07/24/2002 | CN1360573A Phthalamide derivs., intermediates in production thereof, and agricultural/horticultural insecticides and method of using same |
| 07/24/2002 | CN1360498A Carboxylic acid derivs. that inhibit binding of integrins to their receptors |
| 07/24/2002 | CN1359901A Ru-polypyridine complex and its synthesizing process and use |
| 07/23/2002 | US6423869 Polyol-amino acid compounds having anti-helicobacter pylori activity |
| 07/23/2002 | US6423867 Process and intermediate compounds for the preparation of pyrrolidines |
| 07/23/2002 | US6423843 Microbiocides |
| 07/23/2002 | US6423801 Branched polyammonium compounds of high molecular weight and processes for producing said compounds |
| 07/23/2002 | US6423780 Heterobifunctional monomers and uses therefor |
| 07/23/2002 | US6423739 Method for aiding cerebral recovery following neurodegeneration |
| 07/23/2002 | US6423710 Cyclic AMP-specific phosphodiesterase inhibitors |
| 07/23/2002 | US6423690 Antibacterial agents |
| 07/23/2002 | US6423676 O-substituted N,N-diacylhydroxylamine bleach activators and compositions employing the same |
| 07/23/2002 | CA2107675C Antibiotic carbapenem derivatives |
| 07/23/2002 | CA2102180C Novel immunosuppressive pyrrolidine/piperidine/azepane-2-carboxylic acid derivatives |
| 07/18/2002 | WO2002055519A2 Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2r, 4r)-4-hydroxy -6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide |
| 07/18/2002 | WO2002055494A1 Process for preparation of cyclic amine derivatives |
| 07/18/2002 | WO2002055491A2 1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a) |
| 07/18/2002 | WO2002055485A1 Prodrugs of excitatory amino acids |
| 07/18/2002 | WO2002055074A1 Preventives or remedies for arthritis |
| 07/18/2002 | WO2002055073A1 Preventives for arthritis |
| 07/18/2002 | WO2002055025A2 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection |
| 07/18/2002 | WO2002042250B1 DERIVATIVES OF 4-HYDROXYBUTANOIC ACID AND OF ITS HIGHER HOMOLOGUE AS LIGANDS OF η-HYDROXYBUTYRATE (GHB) RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND PHARMACEUTICAL USES |
| 07/18/2002 | WO2002041834A3 Atorvastatin hemi-calcium form vii |
| 07/18/2002 | WO2002031025A3 Biodegradable poly(beta-amino esters) and uses thereof |
| 07/18/2002 | WO2002012224A3 Bicyclic compounds as h3 receptor ligands |
| 07/18/2002 | WO2001072728A3 Novel piperazine derivatives |
| 07/18/2002 | WO2001072685A3 Polyamine analogues as cytotoxic agents |
| 07/18/2002 | US20020094994 Pyrrolidine carboxylic Acid or ester derivatives are useful for treating alpha 4 beta 1 mediated cell adhesion |
| 07/18/2002 | US20020094944 Alkoxy-substituted perfluorocompounds |
| 07/18/2002 | US20020094938 Unsaturated phenolic compound forms an amide bond with amine of fragrance; 2-(2,4-dimethylcyclohex-3-en-1-yl),3-(2-(2,4 -dihydroxyphenyl)ethenylcarbonyl)oxazolidine for example; laundry detergents, shampoos and hair conditioners |
| 07/18/2002 | CA2538995A1 Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2r,4r)-4-hydroxy -6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide |
| 07/18/2002 | CA2434044A1 1,2-disubstituted cyclic inhibitors of matrix metallorproteases and tnf-alpha |
| 07/18/2002 | CA2433713A1 Preventives for arthritis |
| 07/18/2002 | CA2433070A1 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection |
| 07/17/2002 | EP1222171A1 Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof |
| 07/17/2002 | EP1222166A2 Novel p-aminophenols and colorants containing said compounds |
| 07/17/2002 | EP1222152A1 A method for preparing and screening one or more compounds |
| 07/17/2002 | EP1039902A4 Inhibitors of gap junction communication |